OKYO Pharma Limited (NASDAQ:OKYO) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of ordinary shares Announced: US$20M–US$23M · US$1.85 a share · Piper Sandler & Co. Dealers: Piper Sandler & Co. (lead) Use of proceeds: Clinical development of its product candidates, general corporate purposes and working capital | Feb 13, 2026 |
| At-the-market programme of common shares Announced: Leerink Partners LLC Dealers: Leerink Partners LLC (lead) Use of proceeds: Support ongoing clinical development and corporate objectives | Feb 11, 2026 |